返回 Agenda
Session Chair(s)
Fumi Yamamoto
Councilor for Pharmaceutical Affairs, Minister’s Secretariat
Ministry of Health, Labour and Welfare (MHLW), Japan
Speaker(s)
Actual Case of Regulatory Authority Meetings Conducted Simultaneously in Japan, the US and the EU
Kaoru Masuda
Beone Medicines Japan, Japan
Regulatory Affairs, Japan
Consultation Strategy with Health Authorities in Global Simultaneous Development
Eiko Tomita, MBA
Bristol-Myers K.K., Japan
Senior Executive Officer, Vice President, Global Regulatory Sciences Japan
Regulatory View Based on Amassed Cases of Global Clinical Trial Consultation
Naoyuki Yabana, PHD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Director, Office of In Vitro Diagnostics